These findings suggest that tolvaptan substitution may represent a potential therapeutic option for managing azotemia in dogs with congestive heart failure receiving loop diuretics, although prospective controlled studies are needed to confirm clinical benefit.
Park et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: